Creative Biogene Debuts Lentiviral Vector-Based In Vivo CAR-T Development to Shape the Future of Cancer Therapy

Creative Biogene proudly announces the launch of its flagship lentiviral vector-based in vivo CAR-T development services, aimed at revolutionizing cancer treatments through precision medicine.